"R&D productivity remains an ongoing concern. Artificial Intelligence and the accompanying analytics are now so advanced that these tools promise to improve the traditional drug target selection and R&D process."
The PRISME Forum is the biopharmaceutical industry R&D IT leadership group that meets twice a year. It addresses common industry challenges, shares use cases and catalyses more rapid creation, adoption and application of solutions to increase the efficiency and effectiveness of biopharmaceutical R&D.
As such, there is a contribution that the PRISME Forum should make to the development and implementation of AI to reduce the time and cost of bringing new medicines to market to treat unmet patient needs. With that in mind, the PRISME Forum focused its Fall 2017 Technical Meeting on the potential of Artificial Intelligence (AI) to improve biopharma R&D and healthcare.
You just need to REGISTER - its FREE - to read the rest of this article straight away.